Health
CapVest Is in Talks for Drugmaker Stada in €10 Billion Deal
A laboratory at the Stada Arzneimittel factory in Bad Vilbel, Germany.
Photographer: Alex Kraus/BloombergCapVest Partners is in talks to acquire a majority stake in Stada Arzneimittel AG in a deal that could value the German drugmaker at about €10 billion ($11.7 billion) including debt, people familiar with the matter said.
The London-based buyout firm is in discussions with Stada’s private equity owners, Bain Capital and Cinven, about a deal for the drugmaker, which has also been concurrently exploring a potential listing, the people said, asking not to be identified as the matter is private. The buyout shop has backing from large institutional firms in its bid for Stada, the people said.